The American Heart Association’s Call to Action for Reducing the Global Burden of Rheumatic Heart Disease: A Policy Statement From the American Heart Association

Author:

Beaton Andrea,Kamalembo Flavia B.,Dale James,Kado Joseph H.,Karthikeyan Ganesan,Kazi Dhruv S.,Longenecker Chris T.,Mwangi Jeremiah,Okello Emmy,Ribeiro Antonio Luiz P.,Taubert Kathryn A.,Watkins David A.,Wyber Rosemary,Zimmerman Meghan,Carapetis Jonathan,

Abstract

Rheumatic heart disease (RHD) affects ≈40 million people and claims nearly 300 000 lives each year. The historic passing of a World Health Assembly resolution on RHD in 2018 now mandates a coordinated global response. The American Heart Association is committed to serving as a global champion and leader in RHD care and prevention. Here, we pledge support in 5 key areas: (1) professional healthcare worker education and training, (2) technical support for the implementation of evidence-based strategies for rheumatic fever/RHD prevention, (3) access to essential medications and technologies, (4) research, and (5) advocacy to increase global awareness, resources, and capacity for RHD control. In bolstering the efforts of the American Heart Association to combat RHD, we hope to inspire others to collaborate, communicate, and contribute.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference69 articles.

1. Shulman, ST. Rheumatic fever. Kleigman, RM, Stamdpm, BF, St. Geme, J, Shor, NF, eds. In: Nelson Textbook of Pediatrics. 20th ed. Philadelphia, PA: Elsevier; 20161332–1337.

2. Chapelle, C. The New York Heart Association: Origins and Development 1915–1965. New York; New York Heart Association; 1966.

3. American Heart Association: its plan and work.;Churchill JF;Cal West Med,1928

4. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

5. World Health Organization. Rheumatic fever and rheumatic heart disease, 2018: Executive Board, 141st Session: resolutions and decisions, annexes, summary records. Geneva, Switzerlandhttps://www.who.int/cardiovascular_diseases/publications/trs923/en/. Accessed July 25, 2020.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3